Pub. Date : 2021 Aug
PMID : 34484942
4 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Fampridine and Acetazolamide in EA2 and Related Familial EA: A Prospective Randomized Placebo-Controlled Trial. | Acetazolamide | calcium voltage-gated channel subunit alpha1 A | Homo sapiens |
| 2 | Objective: To determine the efficacy and safety of the treatment with prolonged-release 4-aminopyridine (fampridine) and acetazolamide for patients with episodic ataxia type 2 (EA2), patients with EA2 were treated with a random sequence of fampridine, acetazolamide, and placebo in a 3-period crossover trial. | Acetazolamide | calcium voltage-gated channel subunit alpha1 A | Homo sapiens |
| 3 | Objective: To determine the efficacy and safety of the treatment with prolonged-release 4-aminopyridine (fampridine) and acetazolamide for patients with episodic ataxia type 2 (EA2), patients with EA2 were treated with a random sequence of fampridine, acetazolamide, and placebo in a 3-period crossover trial. | Acetazolamide | calcium voltage-gated channel subunit alpha1 A | Homo sapiens |
| 4 | Conclusion: Both fampridine and acetazolamide significantly reduce the number of attacks in patients with EA2 and related EA in comparison to placebo. | Acetazolamide | calcium voltage-gated channel subunit alpha1 A | Homo sapiens |